Hearing Technologies

BALLERUP, DENMARK – GN, a global leader in hearing aid innovation, is has announced the expansion of the ReSound Nexia family. This expansion offers more options for individuals with hearing loss to benefit from advanced hearing technology while embracing the “next era” of Bluetooth connectivity. Alongside the new models, GN is also introducing ReSound Smart Fit 2.0, an updated hearing

STAFA, SWITZERLAND — Phonak, a Sonova brand, has announced the launch of a new family of hearing aids based on the innovative Infinio platform, including the Audéo Sphere Infinio. According to the announcement, it represents the world’s first hearing aid powered by a dedicated real-time AI chip designed for speech-from-noise separation. Addressing the persistent challenge of speech understanding in background

Individuals with hearing loss often face significant challenges in understanding speech, especially in group conversations or noisy environments. These difficulties can lead to social isolation, withdrawal from activities, and reduced workplace participation. To address these issues, the National Acoustic Laboratories (NAL) is leveraging Apple Vision Pro’s mixed reality technology to enhance hearing health and communication accessibility. Introducing NALscribe AR, a

SAN FRANCISCO, CALIFORNIA – Concha Labs has announced the launch of their FDA-cleared Concha Sol™ Hearing Aids, an over-the-counter (OTC) solution offering personalized hearing profiles that users can set up from their iPhones without any appointments. Priced at $1,299 per pair, these hearing aids aim to address the common frustrations of inconvenience, high cost, and poor sound personalization experienced by

July 25, 2024 – London – HearAngel (a LimitEar company) and Sonical, Inc. announced a software licensing agreement to integrate the HearAngel smart hearing safeguarding solution into Sonical’s CosmOS operating system for headphones. This collaboration allows manufacturers using the Sonical platform to offer hearing safeguarding as either a standard feature or user option. “CosmOS is enabling the next generation of

JVC has reported significant success with its innovative hearing rehabilitation approach over the past six months. This advancement leverages Tuned’s technology, resulting in impressive user satisfaction and performance. Leveraging Tuned’s AI Platform Notably, the return rate of JVC’s OTC hearing aids is 13%, significantly lower than the industry average. This success is credited to Tuned’s AI Audiology Platform, which offers

Oticon Medical has announced the U.S. Food and Drug Administration (FDA) clearance and CE mark approval for its first active transcutaneous bone conduction hearing system, the Sentio System. This new system offers the established benefits of the Ponto™ System and introduces a transcutaneous option. The Sentio System consists of the Sentio 1 Mini, an external sound processor, and the Sentio

TEL AVIV, ISRAEL — Bettear, a company specializing in assistive listening technology, has announced the release of its new Auracast™ products: the B-CASTER streamer and B-RTX transceiver. These devices aim to improve how people experience audio in public spaces such as museums, theaters, and convention centers. “Our commitment to inclusive solutions is reflected in the B-CASTER and B-RTX. We believe

NEW YORK, NY — Nagish, a startup utilizing AI to improve communication accessibility for deaf and hard-of-hearing individuals, announced $16 million in new funding. This includes $11 million from a Series A round led by Canaan Partners, with participation from existing investors K5 Global, Tokyo Black, Cardumen Capital, Vertex Ventures Israel, Contour Venture Partners, and Precursor Ventures, along with the

A team of scientists from the University of Sharjah has unveiled a groundbreaking biosensor capable of detecting gene mutations responsible for hearing loss. This innovative sensor, composed of nanoparticles and nanoarrays of silver, provides precise and rapid diagnosis not only for hearing loss genes but also for other conditions such as cancer, Alzheimer’s, and thalassemia. The research, published in the